Deals Shaping The Medical Industry, September 2020
Derived from Biomedtracker, the Deal-Making column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing.
You may also be interested in...
CMOs Face Capacity Challenges, Talent Shortages As Pandemic Increases Demand For Their Services
The need for more plant capacity, process scale-up and skilled workers are major challenges cited by a CMO in producing clinical trial materials for COVID-19 vaccines. Recent white paper says 70% of manufacturers expect to outsource activities due to pandemic.
ORA’s Chief Says Without Additional Funding, Inspections Are In Jeopardy
Without additional funding from Congress, the FDA’s ORA is facing challenges in retaining and hiring new staff, which will impact inspections, said ORA’s chief Michael Rogers during a webinar.
News We’re Watching: Philips Settles Recall Fallout; FDA REdI, Townhalls, Approvals
This week, Philips Respironics reached a $1.1b settlement affecting CPAP and other breathing devices. Toku announced it received US FDA breakthrough device designation for its MyKidneyAI technology. This May, the FDA will hold its REdI conference focusing on innovation in medical product development and hold another townhall focusing on considerations for selecting a sterilization modality.
Table |
---|